Article information
Full text is only aviable in PDF
References
[1.]
J.R. Keane.
Bilateral seventh palsy: analysis of 43 cases and review of the literature.
Neurology, 44 (1994), pp. 1198-1202
[2.]
G. Piñol Ripoll, P. Larrodé Pellicer, I. De la Puerta Gónzalez-Miró, C. Tejero Juste, C. Íñiguez Martínez, S. Santos Lasaosa, et al.
Diplejía facial: variante regional del síndrome de Guillain-Barré.
An Med Interna (Madrid), 24 (2007), pp. 24-26
[3.]
L.B. Schonberger, D.J. Bregman, J.Z. Sullivan-Bolyai, R.A. Keenlyside, D.W. Ziegler, H.F. Retailliau, D.L. Eddins, J.A. Bryan.
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977.
Am J Epidemiol, 110 (1979), pp. 105-123
[4.]
J. Stowe, N. Andrews, L. Wise, E. Miller.
Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.
Am J Epidemiol, 169 (2009), pp. 382-388
[5.]
Summary of 2009 Monovalent H1N1 Influenza Vaccine Data-Vaccine Adverse Event Reporting System. Department of Health and Human Services Centers for Disease Control and Prevention Salfer. Data through December 30, 2009. http://vaers.hhs.gov.
[6.]
M.P. González Santiago, M. Cebrero García, A. Lassaletta Atienza, E. García Frías.
Bilateral facial paralysis as the first manifestation of Guillain-Barré syndrome.
An Pediatr (Barc), 58 (2003), pp. 77-78
[7.]
K. Susuki, M. Koga, K. Hirata, E. Isogai, N. Auki.
A Guillain-Barré syndrome variant with prominent facial diplegia.
J Neurol, 256 (2009), pp. 1899-1905
[8.]
P.J. Marchena, E. Val Pérez, L.P. de Benito, M.J. Hervás.
Diplejía facial periférica como manifestación inicial de un síndrome de Guillain-Barré secundario a una infección aguda por citomegalovirus.
An Med Interna, 22 (2005), pp. 92
[9.]
A.F. Hahn.
Guillain-Barré syndrome.
Lancet, 352 (1998), pp. 635-641
[10.]
K. Susuki, M. Atsumi, M. Koga, K. Hirata, N. Auki.
Acute facial diplegia and hyperreflexia. A Guillain-Barré syndrome variant.
Neurology, 62 (2004), pp. 825-827
[11.]
D.N. Juurlink, T.A. Stukel, J. Kwong, A. Kopp, A. McGeer, R.E. Upshur, et al.
Guillain-Barré syndrome after influenza vaccination in adults.
Arch Intern Med, 166 (2006), pp. 2217-2221
[12.]
D. Evans, S. Cauchemez, F.G. Hayden.
“Prepandemic” inmunization for Novel Influenza Viruses, “Swine Flu” Vaccine, Guillain-Barré Syndrome, and the detection of rare severe adverse events.
J Infect Dis, 200 (2009), pp. 321-328
[13.]
I. Nachamkin, S.V. Shadomy, A.P. Morán, N. Cox, C. Fitzgerald, H. Ung, et al.
Anti-ganglioside antibody induction by Swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome.
J Infect Dis, 198 (2008), pp. 226-233
[14.]
C. Vellozzi, D.R. Burwen, A. Dobardzic, R. Ball, Walton k, P. Haber.
Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
Vaccine, 27 (2009), pp. 2114-2120
Copyright © 2011. Sociedad Española de Neurología
